Combined GPRC5D and BCMA-targeted T-cell Redirecting Therapy in the Treatment of RRMM

被引：0
|
作者：
Godby, Kelly [1 ]
Bal, Susan [1 ]
Giri, Smit [1 ]
Ravi, Gayathri [1 ]
Joiner, Laura [1 ]
Hagedorn, Caitlin [1 ]
Costa, Luciano [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-026
引用
收藏
页码：S55 / S56
页数：2
相关论文
共 50 条
  • [1] Bispecific T-Cell Engagers: Sequencing, BCMA, GPRC5D, and Resistance
    Krishnan, Amrita
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S98 - S99
  • [2] Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody
    Chari, Ajai
    Minnema, Monique C.
    Berdeja, Jesus G.
    Oriol, Albert
    van de Donk, Niels W. C. J.
    Rodriguez-Otero, Paula
    Askari, Elham
    Mateos, Maria-Victoria
    Costa, Luciano J.
    Caers, Jo
    Verona, Raluca
    Girgis, Suzette
    Yang, Shiyi
    Goldsmith, Rachel B.
    Yao, Xiang
    Pillarisetti, Kodandaram
    Hilder, Brandi W.
    Russell, Jeffery
    Goldberg, Jenna D.
    Krishnan, Amrita
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24): : 2232 - 2244
  • [3] BCMA after GPRC5D: Efficacy of BCMA-Directed Therapy on Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Progressing After GPRC5D-Directed Therapy
    Joiner, Laura
    Costa, Luciano
    Giri, Smith
    Ravi, Gayathri
    Godby, Kelly
    Hagedorn, Caitlin
    Bal, Susan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S61 - S62
  • [4] Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy
    Merz, Maximilian
    Dima, Danai
    Hashmi, Hamza
    Ahmed, Nausheen
    Stoelzel, Friedrich
    Holderried, Tobias A. W.
    Fenk, Roland
    Mueller, Fabian
    Tovar, Natalia
    Oliver-Caldes, Aina
    Rathje, Kristin
    Davis, James A.
    Fandrei, David
    Vucinic, Vladan
    Kharboutli, Soraya
    Baermann, Ben-Niklas
    Ayuk, Francis
    Platzbecker, Uwe
    Albici, Anca-Maria
    Schub, Nathalie
    Schmitz, Friederike
    Shune, Leyla
    Khouri, Jack
    Anwer, Faiz
    Raza, Shahzad
    Mcguirk, Joseph
    Mahmoudjafari, Zahra
    Green, Kimberly
    Khandanpour, Cyrus
    Teichert, Marcel
    Jeker, Barbara
    Hoffmann, Michele
    Kroeger, Nicolaus
    von Tresckow, Bastian
    de Larrea, Carlos Fernandez
    Pabst, Thomas
    Abdallah, Al-Ola
    Gagelmann, Nico
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [5] Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma
    de Larrea, Carlos Fernandez
    Staehr, Mette
    Lopez, Andrea, V
    Ng, Khong Y.
    Chen, Yunxin
    Godfrey, William D.
    Purdon, Terence J.
    Ponomarev, Vladimir
    Wendel, Hans-Guido
    Brentjens, Renier J.
    Smith, Eric L.
    BLOOD CANCER DISCOVERY, 2020, 1 (02): : 146 - 154
  • [6] Characterization of dysgeusia and xerostomia in patients with multiple myeloma treated with the T-cell redirecting GPRC5D bispecific antibody talquetamab
    A. M. G. A. Laheij
    N. W. C. J. van de Donk
    Supportive Care in Cancer, 2024, 32
  • [7] GPRC5D CAR T-CELL THERAPY HAS ANTITUMOR ACTIVITY IN MULTIPLE MYELOMA
    不详
    CANCER DISCOVERY, 2019, 9 (06) : 690 - 690
  • [8] Allogeneic CAR-NK Cell Therapy Targeting Both BCMA and GPRC5D for the Treatment of Multiple Myeloma
    Cao, Zhuoxiao
    Yang, Cuiqing
    Wang, Yifang
    Wang, Chao
    Wang, Qingyang
    Ye, Gang
    Liu, Tingting
    Wang, Qin
    Wang, Huanyu
    Gong, Yanxue
    Wang, Biye
    Jiang, Fuwei
    BLOOD, 2022, 140 : 7378 - 7378
  • [9] A novel tri-specific T cell engager targeting BCMA and GPRC5D for treatment of multiple myeloma
    Tan, Yongcong
    Li, Xuezhen
    Yu, Fan
    Xu, Juehua
    Qian, Zhen
    Cao, Yiqi
    Yang, Xueyan
    Du, Qinglin
    Peng, Fei
    Han, Shuhua
    Ding, Qian
    CANCER RESEARCH, 2024, 84 (07)
  • [10] Changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody therapy in patients with relapsed refractory multiple myeloma (RRMM).
    Janardan, Abhishek
    Lindsay, Hammons
    Szabo, Aniko
    Bhatlapenumarthi, Vineel
    Annyapu, Evanka
    Dhakal, Binod
    Narra, Ravi Kishore
    Al Hadidi, Samer
    Radhakrishnan, Sabarinath Venniyil
    Bhutani, Divaya
    Thanendrarajan, Sharmilan
    Siegfried, Janz
    Zangari, Maurizio
    Lentzsch, Suzanne
    van Rhee, Frits
    D'Souza, Anita
    Chakraborty, Rajshekhar
    Schinke, Carolina D.
    Mohan, Meera
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345